Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Looking for help w/numbers for burn rate, cash on hand, et.

<< Previous

Bullboard Posts

Next >>

Comment by BuenaSuertaAtodon Apr 30, 2021 1:40pm

347 Views

Post# 33102242

RE:RE:RE:RE:Looking for help w/numbers for burn rate, cash on hand, et.

Rumpl3StiltSkin, you ended your comment with "cash Infusions from Canadian Govt. and or LKSKI. :-)". I second your ":-)". I'd be very interested to learn more about the prospects of such cash infusions.

I know that grants and such are at times made to publicly traded medical companies that show promise of serving the greater good. Why not TLT?

Rumpl3StiltSkin wrote:

BuenaSuertaAtod wrote: Many thanks for the excellent info Biggainer! I like that most recent 6 quarters show a clear trend downward in burn rate from well over $2 million per quarter to less than $1 million per quarter.

You say that you expect "the burn rate will be much higher as they go through phase II". Is that the nature of a phase II in general? Is that good (because they're on to phase II), bad (because it means that we're that much closer to another PP), or neutral for TLT?

-TIA

Biggainer wrote: Here is the breakdown of their burn rate.

As of 06/30/2019 cash and cash equivalents of $ 1,134,725

On 08/22/2019 - PP of $17,250,000 minus 6% ($ 1,035,000) for finders fee = $ 16,215,000

As of 09/30/2019 cash and cash equivalents of $ 14,975,634 ( - $ 2,374,091) per quarter

As of 12/31/2019 cash and cash equivalents of $ 12,548,550 ( - $ 2,427,085)

As of 03/31/2020 cash and cash equivalents of $ 10,916,159 ( - $ 1,632,391)

As of 06/30/2020 cash and cash equivalents of $ 9,610,914 ( - $ 1,305,245)

As of 09/30/2020 cash and cash equivalents of $ 8,790,901 ( - $ 820,013)

As of 12/31/2020 cash and cash equivalents of $ 7,880,243 (- $ 910,658)

So according to their financials, since end of 06/30/2019 to end of 12/31/2020 or 18 months, they have burned through approximately $9,469,483 or avg. of about $526,082/month.
I also think the burn rate will be much higher as they go through phase II. Just have to see the next quarterly report to get a much clearer picture as to how they stand financially.

BuenaSuertaAtod wrote: I've read here that $390K/mo was burn rate for 2020. $390 x 12mo = $4,680K for the year.

I've also read here that $7,800k cash on hand remains at YE 2020. $7,800K + $4,680K = $11,480K

In Jan 2020 units were issued that raised total gross funds of at least $17,250,000. Net would be quite a bit less than that. Just the same, if $4,680 was what they burned through in 2020 there ought to be more cash left over from that PP than $7,800K shouldn't there?

Where have my numbers gone wrong?

At the current burn rate trend, shown above, it appears that TLT is trying hard to get Phase 2 across the finish line. I think max people treated will be ~ 50. then we will see a strategic halt in phase 2 as we await FDA BTD and AA. My guess is TLT will get CR %s up into the 80s.

I do think we will see an increase in burn rate, but it might not go up dramatically as we have seen the trend go down even though treatments have resumed. Current burn rate, assuming we have ~ $7M, gets us through June 2022. We will know a hella lot by then, Covid vaccine/treatment/, CR %s for NMIBC roughly, Phase 1s announced/commenced for other indications, cash Infusions from Canadian Govt. and or LKSKI. :-)